Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03244995 · ClinicalTrials.gov registry record · NA

Mind-Body Intervention in Glioma Couples

A NA study of Glioblastoma and Metastatic Malignant Neoplasm in the Brain, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT03244995: Active NA study of Glioblastoma and Metastatic Malignant Neoplasm in the Brain, sponsored by M.D. Anderson Cancer Center.

NCT03244995 is a NA study of Glioblastoma and Metastatic Malignant Neoplasm in the Brain that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 74 participants, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03244995, a NA study of Glioblastoma and Metastatic Malignant Neoplasm in the Brain, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well a couple-based mind body program works in improving spiritual, psychosocial, and physical quality of life in patients with high or low grade glioma or tumors that have spread to the brain and their partners. A couple-based mind body program may help to improve spiritual well-being, sleep difficulties, depressive symptoms, and overall quality of life in patients with glioma or tumors that have spread to the brain and their partners.

Primary Outcome

Trial considered feasible if 50% of eligible couples consent. Will calculate rates, frequencies, and 90% confidence intervals (CIs), as applicable.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • PROCEDURE Mind-Body Intervention Procedure

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2017-08-06
Est. Completion 2028-12-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT03244995 still lists

NCT03244995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (32% lower).

The record links to 6 conditions, with Glioblastoma appearing as the primary indexed condition, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03244995 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03244995 about?

NCT03244995 is a clinical study titled "Mind-Body Intervention in Glioma Couples". This trial studies how well a couple-based mind body program works in improving spiritual, psychosocial, and physical quality of life in patients with high or low grade glioma or tumors that have spread to the brain and their partners. A couple-based mind body program may help to improve spiritual w...

What is the current status of trial NCT03244995?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2017-08-06. Estimated completion is 2028-12-31.

What conditions does trial NCT03244995 study?

This clinical trial studies the following conditions: Glioblastoma, Metastatic Malignant Neoplasm in the Brain, Malignant Glioma, Low Grade Glioma, WHO Grade III Glioma.

What interventions are being tested in trial NCT03244995?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Mind-Body Intervention Procedure (PROCEDURE).

Who is sponsoring clinical trial NCT03244995?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03244995 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glioblastoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03244995's enrollment target sits among peer trials

74 62nd of 199 higher than 136 of 199 other Glioblastoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glioblastoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03244995, the US trial registry maintained by the National Library of Medicine. NCT03244995 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.